申请人:Abbott Laboratories
公开号:US07981888B2
公开(公告)日:2011-07-19
Compounds of Formula I
wherein A1, B1, C1, D1, E1, F1 and L1 are as defined herein, which inhibit the activity of anti-apoptotic Mcl-1 protein, compositions containing the compounds, and methods of treating diseases involving overexpressed or unregulated Mcl-1 protein, such as leukemia and lymphoma, are disclosed.
本文披露了化学式I的化合物,其中A1、B1、C1、D1、E1、F1和L1的定义如本文所述,这些化合物抑制抗凋亡Mcl-1蛋白的活性,包含这些化合物的组合物,以及治疗涉及过度表达或未调节的Mcl-1蛋白的疾病的方法,如白血病和淋巴瘤。